MedWatch

ALK buys shares in new biotech firm with experienced leader

A one-year-old biotech firm can now count one of Denmark's largest pharmaceutical companies among its owners. ALK hopes the company is sitting on an affective allergy treatment.

Søren Mouritsen, CEO of Betamab, is happy to get ALK onboard as an investor in the company. | Foto: Betamab/ PR

Læs artiklen gratis

Registrer med din E-mail.
Det kræver intet kreditkort.

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Læs også

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier